4,007
Views
38
CrossRef citations to date
0
Altmetric
Articles

Viral RNA level, serum antibody responses, and transmission risk in recovered COVID-19 patients with recurrent positive SARS-CoV-2 RNA test results: a population-based observational cohort study

ORCID Icon, , ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , , , , , , , ORCID Icon, , & show all
Pages 2368-2378 | Received 03 Sep 2020, Accepted 09 Oct 2020, Published online: 05 Nov 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Yun Yan, Lei Yang, Xiaoli Li, Jian Hao, Bijue Wang, Dan Wang & Junning Wang. (2022) Clinical Characteristics in Patients with Redetected Positive RNA Test After Recovery from Foreign-Imported COVID-19 Cases in Xi’an, China. Infection and Drug Resistance 15, pages 3295-3307.
Read now

Articles from other publishers (37)

Huang Zhi Min, Li Gui Lian, Yang Zheng Rong, Zhou Lin, Jiang Min, Li Hao, Zhong Yi Fan, Jiang Yi Xiang, Wang Xiao Hui & He Tai Ping. (2024) Analysis of Differences in Lymphocyte Subsets and CD4+ T Cells Immune Activation Between Re-detectable Positive and Non-re-detectable Positive COVID-19 Convalescent Patients. Archives of Clinical Infectious Diseases 19:1.
Crossref
Lantian Tang, Hanxi Ding, Qi Zeng, Renjie Zhou, Bo Liu & Xi Huang. (2023) Engineered Nanovesicles Expressing Bispecific Single Chain Variable Fragments to Protect against SARS-CoV-2 Infection. ACS Biomaterials Science & Engineering 9:12, pages 6783-6796.
Crossref
Torao Ishida, Ken Takagi, Guifeng Wang, Nobuyuki Tanahashi, Jun Kawanokuchi, Hisayo Takagi, Yi Guo & Ning Ma. (2023) A Greater Increase in Complement C5a Receptor 1 Level at Onset and a Smaller Decrease in Immunoglobulin G Level after Recovery in Severer Coronavirus Disease 2019 Patients: A New Analysis of Existing Data with a New Two-Tailed t-Test. Biology 12:9, pages 1176.
Crossref
Carlos K H Wong, Kristy T K Lau, Ivan C H Au, Eric H Y Lau, Leo L M Poon, Ivan F N Hung, Benjamin J Cowling & Gabriel M Leung. (2023) Viral burden rebound in hospitalised patients with COVID-19 receiving oral antivirals in Hong Kong: a population-wide retrospective cohort study. The Lancet Infectious Diseases 23:6, pages 683-695.
Crossref
Cheng-Yi Hu, Yi Lei, Yu-Wen Tang, Wen-Shuai Cui, Pei-Lian Wu, Yan-Fang Li, Yan Zhou, Xin-Yan Li, Hao Cui, Lu-Shan Xiao & Zhu-Xiang Zhao. (2023) Characteristics of patients with SARS-COV-2 PCR re-positivity after recovering from COVID-19. Epidemiology and Infection 151.
Crossref
Jing Wang, Shu-Xiang Zhang, Jian-Rong Na, Li-Ling Zhang, Yin-Hao Zhang, Jiao-Jiao Chu, Lei Guo, Mei Yan, Yu-Ting Li & Wei Zhou. (2022) A comparative study of virus nucleic acid re-positive and non-re-positive patients infected with SARS-CoV-2 Delta variant strain in the Ningxia Hui Autonomous Region. Frontiers in Public Health 10.
Crossref
Pingping Zhang, Baisheng Li, Yao Wang, Wei Min, Xiaohui Wang, Yugui Zhou, Zhencui Li, Yong Zhao, Huan Zhang, Min Jiang, Huanying Zheng, Chao Yang, Wei Zhang, Le Zuo, Qi Gao, Zhengrong Yang, Yanzhao Li, Tiejian Feng, Changqing Lin, Qinghua Hu, Tie Song & Ruifu Yang. (2022) Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects. BMC Microbiology 22:1.
Crossref
Tianning Li, Meng Han, Jingyu Wang, Chunlei Zhou & Hong Mu. (2022) Clinical characteristics and risks of the convalescent COVID-19 patients with re-detectable positive RNA test: a 430 patients with Omicron infected cross-sectional survey in Tianjin, China. Journal of Infection and Public Health 15:12, pages 1409-1414.
Crossref
Qi-Xiang Song, Zhichao Jin, Weilin Fang, Chenxu Zhang, Chi Peng, Min Chen, Xu Zhuang, Wei Zhai, Jun Wang, Min Cao, Shun Wei, Xia Cai, Lei Pan, Qingrong Xu & Junhua Zheng. (2022) The machine learning model based on trajectory analysis of ribonucleic acid test results predicts the necessity of quarantine in recurrently positive patients with SARS-CoV-2 infection. Frontiers in Public Health 10.
Crossref
Rafel Ramos, Lia Alves-Cabratosa, Jordi Blanch, Àlex Pèlach, Laura Albert, Quirze Salomó, Sílvia Cabarrocas, Marc Comas-Cufí, Ruth Martí-Lluch, Anna Ponjoan, Maria Garcia-Gil, Salomé de Cambra, Albert d’Anta, Elisabet Balló, Albert Alum & Rosa Núria Aleixandre. (2022) SARS-CoV-2 transmission risk screening for safer social events: a non-randomised controlled study. Scientific Reports 12:1.
Crossref
C.J. Toro-Huamanchumo, M.M. Hilario-Gomez, L. Pinedo-Castillo, C.J. Zumarán-Nuñez, F. Espinoza-Gonzales, J. Caballero-Alvarado, A.J. Rodriguez-Morales & J.J. Barboza. (2022) Clinical and epidemiological features of patients with COVID-19 reinfection: a systematic review. New Microbes and New Infections 48, pages 101021.
Crossref
Maryam Koupaei, Mohamad Hosein Mohamadi, Ilya Yashmi, Amir Hossein Shahabi, Amir Hosein Shabani, Mohsen Heidary & Saeed Khoshnood. (2022) Clinical manifestations, treatment options, and comorbidities in COVID‐19 relapse patients: A systematic review. Journal of Clinical Laboratory Analysis 36:5.
Crossref
Barik A. Salih. (2022) The effectiveness of the immune responses to SARS-CoV-2. Reviews in Medical Microbiology 33:2, pages 92-99.
Crossref
Andrea Knies, Dennis Ladage, Ralf J. Braun, Janine Kimpel & Miriam Schneider. (2021) Persistence of humoral response upon SARS‐CoV‐2 infection. Reviews in Medical Virology 32:2.
Crossref
Yuan Hou, Yadi Zhou, Lara Jehi, Yuan Luo, Michaela U. Gack, Timothy A. Chan, Haiyuan Yu, Charis Eng, Andrew A. Pieper & Feixiong Cheng. (2022) Aging‐related cell type‐specific pathophysiologic immune responses that exacerbate disease severity in aged COVID‐19 patients. Aging Cell 21:2.
Crossref
Abolfazl Akbari, Amirhossein Fathabadi, Mahya Razmi, Ahmadreza Zarifian, Mahdi Amiri, Alireza Ghodsi & Elnaz Vafadar Moradi. (2022) Characteristics, risk factors, and outcomes associated with readmission in COVID-19 patients: A systematic review and meta-analysis. The American Journal of Emergency Medicine 52, pages 166-173.
Crossref
Zhian Salah Ramzi. (2022) Hospital readmissions and post-discharge all-cause mortality in COVID-19 recovered patients; A systematic review and meta-analysis. The American Journal of Emergency Medicine 51, pages 267-279.
Crossref
Sahar Sotoodeh Ghorbani, Niloufar Taherpour, Sahar Bayat, Hadis Ghajari, Parisa Mohseni & Seyed Saeed Hashemi Nazari. (2021) Epidemiologic characteristics of cases with reinfection, recurrence, and hospital readmission due to COVID‐19: A systematic review and meta‐analysis. Journal of Medical Virology 94:1, pages 44-53.
Crossref
Seth Kofi Abrokwa, Sophie Alice Müller, Alba Méndez-Brito, Johanna Hanefeld & Charbel El Bcheraoui. (2021) Recurrent SARS-CoV-2 infections and their potential risk to public health – a systematic review. PLOS ONE 16:12, pages e0261221.
Crossref
Natalie Yan-Lin Pang, Alexander Shao-Rong Pang, Vincent T. Chow & De-Yun Wang. (2021) Understanding neutralising antibodies against SARS-CoV-2 and their implications in clinical practice. Military Medical Research 8:1.
Crossref
Hong Zhao, Chi Zhang, Xian-Xiang Chen, Qi Zhu, Wen-Xiang Huang, Yi-Lan Zeng, Ying-Xia Liu, Guo-Jun Li, Wei-Jun Du, Jing Yao, Jia-Wen Li, Peng Peng & Gui-Qiang Wang. (2021) The relationship between SARS-COV-2 RNA positive duration and the risk of recurrent positive. Infectious Diseases of Poverty 10:1.
Crossref
Xiaomin Wu, Zengmiao Wang, Zhenyu He, Yapin Li, Yating Wu, Huaiji Wang, Yonghong Liu, Fanghua Hao & Huaiyu Tian. (2021) A follow-up study shows that recovered patients with re-positive PCR test in Wuhan may not be infectious. BMC Medicine 19:1.
Crossref
Ying Qian, Wei Xie, Jidi Zhao, Ming Xue, Shiyong Liu, Lei Wang, Wanglai Li, Luojia Dai & Yuyang Cai. (2021) Investigating the effectiveness of re-opening policies before vaccination during a pandemic: SD modelling research based on COVID-19 in Wuhan. BMC Public Health 21:1.
Crossref
Kevin Escandón, Angela L. Rasmussen, Isaac I. Bogoch, Eleanor J. Murray, Karina Escandón, Saskia V. Popescu & Jason Kindrachuk. (2021) COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection. BMC Infectious Diseases 21:1.
Crossref
Yan Zhan, Yufang Zhu, Shanshan Wang, Shijun Jia, Yunling Gao, Yingying Lu, Caili Zhou, Ran Liang, Dingwen Sun, Xiaobo Wang, Zhibing Hou, Qiaoqiao Hu, Peng Du, Hao Yu, Chang Liu, Miao Cui, Gangling Tong, Zhihua Zheng, Yunsheng Xu, Linyu Zhu, Jin Cheng, Feng Wu, Yulan Zheng, Peijun Liu & Peng Hong. (2021) SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection. Signal Transduction and Targeted Therapy 6:1.
Crossref
Claudius Grehl, Christoph Schultheiß, Katrin Hoffmann, Mascha Binder, Thomas Altmann, Ivo Grosse & Markus Kuhlmann. (2021) Detection of SARS-CoV-2 Derived Small RNAs and Changes in Circulating Small RNAs Associated with COVID-19. Viruses 13:8, pages 1593.
Crossref
Salvatore Zaffina, Paola Lanteri, Francesco Gilardi, Sergio Garbarino, Annapaola Santoro, Maria Rosaria Vinci, Rita Carsetti, Alessandro Scorpecci, Massimiliano Raponi, Nicola Magnavita & Vincenzo Camisa. (2021) Recurrence, Reactivation, or Inflammatory Rebound of SARS-CoV-2 Infection With Acute Vestibular Symptoms: A Case Report and Revision of Literature. Frontiers in Human Neuroscience 15.
Crossref
Hong Zhao, Chi Zhang, Qi Zhu, Xianxiang Chen, Guilin Chen, Wenjin Sun, Zuohan Xiao, Weijun Du, Jing Yao, Guojun Li, Yanhua Ji, Niuniu Li, Yujin Jiang, Ying Wang, Qingjin Zeng, Wei Li, Beilei Gong, Xianyou Chang, Feng Zhu, Xiufeng Jiang, Jiawen Li, Zhao Wu, Yingxia Liu, Peng Peng & Guiqiang Wang. (2021) Favipiravir in the treatment of patients with SARS-CoV-2 RNA recurrent positive after discharge: A multicenter, open-label, randomized trial. International Immunopharmacology 97, pages 107702.
Crossref
Xiujuan Tang, Salihu S. Musa, Shi Zhao & Daihai He. (2021) Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review. Frontiers in Public Health 9.
Crossref
Annukka A R Antar, Tong Yu, Nora Pisanic, Razvan Azamfirei, Jeffrey A Tornheim, Diane M Brown, Kate Kruczynski, Justin P Hardick, Thelio Sewell, Minyoung Jang, Taylor Church, Samantha N Walch, Carolyn Reuland, Vismaya S Bachu, Kirsten Littlefield, Han-Sol Park, Rebecca L Ursin, Abhinaya Ganesan, Oyinkansola Kusemiju, Brittany Barnaba, Curtisha Charles, Michelle Prizzi, Jaylynn R Johnstone, Christine Payton, Weiwei Dai, Joelle Fuchs, Guido Massaccesi, Derek T Armstrong, Jennifer L Townsend, Sara C Keller, Zoe O Demko, Chen Hu, Mei-Cheng Wang, Lauren M Sauer, Heba H Mostafa, Jeanne C Keruly, Shruti H Mehta, Sabra L Klein, Andrea L Cox, Andrew Pekosz, Christopher D Heaney, David L Thomas, Paul W Blair & Yukari C Manabe. (2021) Delayed Rise of Oral Fluid Antibodies, Elevated BMI, and Absence of Early Fever Correlate With Longer Time to SARS-CoV-2 RNA Clearance in a Longitudinally Sampled Cohort of COVID-19 Outpatients. Open Forum Infectious Diseases 8:6.
Crossref
Keun-Mi Lee, Hae-Jin Ko, Geon Ho Lee, A-Sol Kim & Dong-Wook Lee. (2021) A Well-Structured Follow-Up Program is Required after Recovery from Coronavirus Disease 2019 (COVID-19); Release from Quarantine is Not the End of Treatment. Journal of Clinical Medicine 10:11, pages 2329.
Crossref
Adrián Sánchez-Montalvá, Candela Fernández-Naval, Andrés Antón, Xavier Durà, Alba Vimes, Aroa Silgado, Fernando Velásquez-Orozco, Juan Espinosa-Pereiro, Fernando Salvador, Tomás Pumarola, Benito Almirante & Juliana Esperalba. (2021) Risk of SARS-CoV-2 Infection in Previously Infected and Non-Infected Cohorts of Health Workers at High Risk of Exposure. Journal of Clinical Medicine 10:9, pages 1968.
Crossref
Fanni Dembrovszky, Szilárd Váncsa, Nelli Farkas, Bálint Erőss, Lajos Szakó, Brigitta Teutsch, Stefania Bunduc, Rita Nagy, Dóra Dohos, Szabolcs Kiss, Andrea Párniczky, Zsófia Vinkó, Zoltán Péterfi & Péter Hegyi. (2021) Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis. Viruses 13:5, pages 809.
Crossref
Florian Deisenhammer, Wegene Borena, Angelika Bauer, Janine Kimpel, Dagmar Rudzki, Kathrin Schanda, Jonas Egeter, Katharina Hüfner, Barbara Sperner-Unterweger & Markus Reindl. (2020) 6-month SARS-CoV-2 antibody persistency in a Tyrolian COVID-19 cohort. Wiener klinische Wochenschrift 133:7-8, pages 351-358.
Crossref
Peter Simmonds, Sarah Williams & Heli Harvala. (2021) Understanding the outcomes of COVID-19 – does the current model of an acute respiratory infection really fit?. Journal of General Virology 102:3.
Crossref
Alessandro Fiocchi & Erika Jensen-Jarolim. (2021) SARS-COV-2, can you be over it?. World Allergy Organization Journal 14:2, pages 100514.
Crossref
Carlos J. Toro-Huamanchumo, Maryori M. Hilario-Gomez, Liseth Pinedo-Castillo, Carlos J. Zumarán-Nuñez, Fiorella Espinoza-Gonzales, José Caballero-Alvarado, Alfonso Rodriguez-Morales & Joshuan J. Barboza. (2022) Clinical and Epidemiological Features of Patients with COVID-19 Reinfection: A Systematic Review. SSRN Electronic Journal.
Crossref